Repression of YAP by NCTD disrupts NSCLC progression

The efficacy of available lung cancer therapeutic interference is significantly limited by various resistance mechanisms to those drugs. Activation of the oncogene YAP underlying the initiation, progression, and metastasis of lung cancer associates with poor prognosis and confers drug resistance aga...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Jiwei, Wu, Yan, Yang, Lijuan, Du, Jing, Gong, Kaikai, Chen, Weiwei, Dai, Juanjuan, Li, XueLin, Xi, Sichuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356801/
https://www.ncbi.nlm.nih.gov/pubmed/27903989
http://dx.doi.org/10.18632/oncotarget.13668

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356801/
https://www.ncbi.nlm.nih.gov/pubmed/27903989
http://dx.doi.org/10.18632/oncotarget.13668

Ejemplares similares